Patent · US Active

Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

US11578081B1 · kind B1 · utility

0Cited by

0References

8Claims

0Family size

Assignees

ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD. · CN
Medshine Discovery Inc. · CN

Inventors

Fei Hong · San Diego, US
Jinming Huang · Lo Wu, CN
Jinxia Lin · Zhangzhou, CN
Yichao Zhuang · Zhangzhou, CN
Zhiyi Luo · Zhangzhou, CN
Xiaoping Zheng · Shanghai, CN
Zhigan Jiang · Shanghai, CN
Haiying He · Shanghai, CN

Key dates

Filing date	Dec 4, 2020
Grant date	Feb 14, 2023
Priority date	—
Expiry date	Dec 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a crystal form (I) as an inhibitor of ACC1 and ACC2, a preparation method therefor, and the use thereof in the preparation of a drug as an inhibitor of ACC1 and ACC2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.